Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss state of the pharmaceutical landscape, future of drug pricing, drug ...

Why is the U.S. at risk of losing its measles elimination status? And what did top CMS official Mehmet Oz tell hospital ...

An Aim stalwart for decades, Hutchmed (HCM) has often suffered by association, whether it is the generally depressed ...

Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

Effective procurement is not merely about finding the lowest-cost materials; it requires a clear communication channel ...

Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative ...

CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...

Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks. BioSpace spoke to investors at JPM26 to get their ...

Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket because the success rate of new drug development is extremely low, and the costs ...

New 'AI GYM for Science' dramatically boosts the biological and chemical intelligence of any causal or frontier LLMUp to 10x performance gains on key drug discovery benchmarks compared to LLMs that ...

The strongest robotics growth is expected to be in manufacturing, logistics and warehousing, retail and hospitality, ...

Endometriosis is a prevalent yet underdiagnosed disease affecting a large population of women of reproductive age, with a substantial and lasting impact on quality of life and fertility. While rising ...